Related Experiment Videos

Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid

A Matsumoto1, Y Fujiwara

  • 1Department of Radiation Biophysics, Kobe University School of Medicine, Japan.

Insights

Familial Alzheimer's disease (FAD) shows abnormal processing of beta-amyloid precursor protein (APP). This study indicates deficient intra-beta A4 proteolysis in FAD, potentially causing amyloid deposits in Alzheimer's disease (AD) brains.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is characterized by amyloid deposits.
  • Familial Alzheimer's disease (FAD) presents with abnormal processing of beta-amyloid precursor protein (APP).

Purpose of the Study:

  • To investigate the molecular mechanisms underlying APP processing abnormalities in FAD.
  • To identify potential causes for increased amyloid deposition in FAD.

Main Methods:

  • Western blot analysis of lymphoblastoid cell lines (LCLs) from FAD patients.
  • Antibody-based detection of APP and its processing products.
  • Characterization of protein complexes in FAD LCL media and lysates.

Main Results:

  • Increased amounts of a 120 kD complex involving secreted APP's Kunitz protease inhibitor domain and an unidentified serine protease were found in FAD LCL media.
  • Slower APP processing and elevated levels of 16 kD C-terminal preamyloid were observed in FAD LCL lysates.
  • Evidence suggests a deficiency in intra-beta A4 proteolysis in FAD.

Conclusions:

  • Deficient intra-beta A4 proteolysis in FAD may lead to the accumulation of amyloid deposits in AD brains.
  • Identified a novel FAD-specific serine protease involved in APP processing.
  • Highlights potential therapeutic targets for FAD by addressing APP processing defects.

Related Concept Videos